Lymphomas and leukemias in mice

Experimental and Toxicologic Pathology

Volumn 57, Issue 5-6, 2006, Pages 377-381

  Ward, Jerrold M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Carcinogenesis; Immunohistochemistry; Leukaemia; Lymphocytes; Lymphoma; Mice; Spleen

Indexed keywords

AGING; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CARCINOGENESIS; FOLLICULAR LYMPHOMA; IMMUNOHISTOCHEMISTRY; IRRADIATION; LEUKEMIA; LEUKEMOGENESIS; LYMPHOBLASTOMA; LYMPHOMA; MESENTERY LYMPH NODE; NONHUMAN; PEYER PATCH; RETROVIRUS; SPLEEN; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 33745286296     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.01.007     Document Type: Article

References (26)

1. Boorman G.A., Rafferty C.N., Ward J.M., and Sills R.C. Leukemia and lymphoma incidence in rodents exposed to low-frequency magnetic fields. Radiat Res 153 (2000) 627-636
2. Borowsky A.D., Munn R.J., Galvez J.J., Cardiff R.D., Ward J.M., Morse III H.C., et al. Mouse models of human cancers (part 3). Comp Med 54 (2004) 258-270
3. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., et al. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96 (1999) 1977-1982
4. Frith C.H., and Wiley L.D. Morphologic classification and correlation of incidence of hyperplastic and neoplastic lesions in mice with age. J Gerontol 36 (1981) 534-545
5. Frith C.H., Ward J.M., and Chandra M. The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol 21 (1993) 206-218
6. Frith C.H., Ward J.M., Fredrickson T., and Harleman J.H. Neoplastic lesions of the hematopoietic system. In: Mohr U., Dungworth D.L., Capen C.C., Carlton W.W., Sundberg J.P., and Ward J.M. (Eds). Pathobiology of aging mice (1996), ILSI Press, Washington, DC 219-235
7. Frith C.H., Ward J.M., Harleman J.H., Stromberg P.C., Halm S., Inoue T., et al. Hematopoietic system. In: Mohr U. (Ed). International classification of rodent tumors. The mouse (2001), Springer, Berlin 417-451
8. Gold L.S., Manley N.B., Slone T.H., and Ward J.M. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol 29 (2001) 639-652
9. Haines D.C., Chattopadhyay S., and Ward J.M. Pathology of aging B6;129 mice. Toxicol Pathol 29 (2001) 653-661
10. Haseman J.K., Huff J., and Boorman G.A. Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol 12 (1984) 126-135
11. Haseman J.K., Boorman G.A., and Huff J. Value of historical control data and other issues related to the evaluation of long-term rodent carcinogenicity studies. Toxicol Pathol 25 (1997) 524-527
12. Haseman J.K., Elwell M.R., and Hailey J.R. Neoplasm incidences in B6C3F1 mice: NTP historical data. Pathology of the mouse (1999) 679-689
13. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. Tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon p. 351
14. In: Jones T.C., Ward J.M., and Mohr U. (Eds). Hemopoietic system (1990), Springer, Berlin p. 336
15. Kogan S.C. Myeloid malignancies. In: Holland E.C. (Ed). Mouse models of human cancer (2004), Wiley-Liss, Hoboken, NJ 215-236
16. Kogan S.C., Ward J.M., Anver M.R., Berman J.J., Brayton C., Cardiff R.D., et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100 (2002) 238-245
17. Maita K., Hirano M., Harada T., Mitsumori K., Yoshida A., Takahashi K., et al. Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol 16 (1988) 340-349
18. Melnick R.L., and Sills R.C. Comparative carcinogenicity of 1,3-butadiene, isoprene, and chloroprene in rats and mice. Chem Biol Interact 135-136 (2001) 27-42
19. Morse III H.C., Qi C.F., Chattopadhyay S.K., Hori M., Taddesse-Heath L., Ozato K., et al. Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res 25 (2001) 719-733
20. Morse III H.C., Anver M.R., Fredrickson T.N., Haines D.C., Harris A.W., Harris N.L., et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100 (2002) 246-258
21. Son W.C., and Gopinath C. Early occurrence of spontaneous tumors in CD-1 mice and Sprague-Dawley rats. Toxicol Pathol 32 (2004) 371-374
22. Taddesse-Heath L., Chattopadhyay S.K., Dillehay D.L., Lander M.R., Nagashfar Z., Morse III H.C., et al. Lymphomas and high-level expression of murine leukemia viruses in CFW mice. J Virol 74 (2000) 6832-6837
23. Tarone R.E., Chu K.C., and Ward J.M. Variability in the rates of some common naturally occurring tumors in Fischer 344 rats and (C57BL/6N×C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst 66 (1981) 1175-1181
24. Teitell M.A., and Pandolfi P.P. Lymphoid malignancies. In: Holland E.C. (Ed). Mouse models of human cancer (2004), Wiley-Liss, Hoboken, NJ 237-259
25. Ward J.M., Tadesse-Heath L., Perkins S.N., Chattopadhyay S.K., Hursting S.D., and Morse III H.C. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice. Lab Invest 79 (1999) 3-14
26. Ward J.M., Anver M.R., Mahler J.F., and Devor-Henneman D.E. Pathology of mice commonly used in genetic engineering (C57BL/6; 129; B6,129 and FVB/N). In: Ward J.M., Mahler J.F., Maronpot R.R., and Sundberg J.P. (Eds). Pathology of genetically engineered mice (2000), Iowa State University Press, Ames, Iowa 161-179